Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
2160.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-0.08
vs -74.82
Q4.20
N/A
-0.19
vs -74.68
Q2.21
N/A
-0.04
vs -0.08
Q4.21
N/A
-0.06
vs -0.19
Q2.22
N/A
-0.06
vs -0.04
Q4.22
N/A
-0.16
vs -0.06
Q2.23
N/A
-0.08
vs -0.06
Q4.23
N/A
-0.14
vs -0.16
Q2.24
N/A
-0.03
vs -0.08
Q4.24
+102%
0
vs -0.14
Sales Growth
YoY
Current
Estimates
Q2.20
+261%
38.9M vs 10.8M
Q4.20
+505%
65.1M vs 10.8M
Q2.21
+122%
86.2M vs 38.9M
Q4.21
+76%
114.6M vs 65.1M
Q2.22
+45%
124.8M vs 86.2M
Q4.22
+10%
126.2M vs 114.6M
Q2.23
+41%
176.4M vs 124.8M
Q4.23
+27%
159.8M vs 126.2M
Q2.24
+26%
223.1M vs 176.4M
Q4.24
-13%
138.4M vs 159.8M
Return on Equity
QoQ
Q2.21
-2%
-0.02
vs 0.8
Q4.21
-4%
-0.04
vs -0.02
Q2.22
-4%
-0.04
vs -0.04
Q4.22
-12%
-0.12
vs -0.04
Q2.23
-7%
-0.07
vs -0.12
Q4.23
-13%
-0.13
vs -0.07
Q2.24
-3%
-0.03
vs -0.13
Q4.24
+0%
0
vs -0.03
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
260%2025-Revenue
-115%2025-EPS
-418%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
HKSE
Unprofitable
EPS improving
Unprofitable
EPS improving
0.03Â ( 3.26%)
Relative Strenght
Volume Buzz
25%
Earning Acce
Yes
Dist 52w H.
31%Relative Strength
2160.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 2160.HK compares to sector?
2160.HK
-41x